Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miquel Massons

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Neurologia|May 26, 2026
Bilateral carotid arteriopathy associated with GD: a case reportMiquel Massons, Alejandro Rodríguez-Vázquez, Alex Mesa, et al.
Neurologia|March 28, 2026
Acute extensive leukoencephalopathy secondary to transdermal fentanyl and oral tapentadol intoxication: a case reportMiquel Massons, Jorge Luis Núñez-Pizarro, Juliana Zapatero, et al.
European Stroke Journal|September 25, 2023
Stroke Unit as an alternative to Intensive Care Unit for initial hospital admission of low-grade non-aneurysmal subarachnoid haemorrhage: A safety and cost-minimisation analysisDaniel Santana, Alejandra Mosteiro, Laura Llull, et al.
Neurology|September 8, 2025
α-Synuclein Seed Amplifications Assay in a Cohort With Cognitive Impairment: Performance and Interactions With CSF and Plasma BiomarkersDiana Esteller-Gauxax, Agnès Pérez Millan, Jordi Sarto, et al.
Alzheimer'S Research & Therapy|May 8, 2026
Proteomic analysis in Alzheimer's disease and other dementias: a focus on sex-specific differencesAina Comas-Albertí, Albert Lladó, Diana Esteller-Gauxax, et al.
Journal of Neurology|January 23, 2025
Accuracy and clinical applicability of plasma tau 181 and 217 for Alzheimer's disease diagnosis in a memory clinic cohortJordi Sarto, Diana Esteller-Gauxax, Núria Guillén, et al.
Journal of Neurology|December 16, 2025
Plasma p-Tau217 and GFAP predict widespread cognitive decline in Alzheimer's diseaseNúria Guillén, Diana Esteller, Jordi Sarto, et al.
Neurology|July 1, 2026
Neuropsychological Profile and Cognitive Trajectories of Patients With Biomarker Evidence of Alzheimer Disease or Dementia With Lewy bodiesAdrià Tort-Merino, Diana Esteller-Gauxax, Agnès Pérez-Millan, et al.
Annals of Clinical and Translational Neurology|April 13, 2026
Predictive Ability of Plasma p-tau217 for β-Amyloid Status: A Prospective Multicenter StudyMiquel Massons, Nuria Guillen, Jordi Sarto, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersMiquel Massons, Jordi Sarto, Núria Guillén, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Neurologia|May 26, 2026
Bilateral carotid arteriopathy associated with GD: a case reportMiquel Massons, Alejandro Rodríguez-Vázquez, Alex Mesa, et al.
Neurologia|March 28, 2026
Acute extensive leukoencephalopathy secondary to transdermal fentanyl and oral tapentadol intoxication: a case reportMiquel Massons, Jorge Luis Núñez-Pizarro, Juliana Zapatero, et al.
European Stroke Journal|September 25, 2023
Stroke Unit as an alternative to Intensive Care Unit for initial hospital admission of low-grade non-aneurysmal subarachnoid haemorrhage: A safety and cost-minimisation analysisDaniel Santana, Alejandra Mosteiro, Laura Llull, et al.
Neurology|September 8, 2025
α-Synuclein Seed Amplifications Assay in a Cohort With Cognitive Impairment: Performance and Interactions With CSF and Plasma BiomarkersDiana Esteller-Gauxax, Agnès Pérez Millan, Jordi Sarto, et al.
Alzheimer'S Research & Therapy|May 8, 2026
Proteomic analysis in Alzheimer's disease and other dementias: a focus on sex-specific differencesAina Comas-Albertí, Albert Lladó, Diana Esteller-Gauxax, et al.
Journal of Neurology|January 23, 2025
Accuracy and clinical applicability of plasma tau 181 and 217 for Alzheimer's disease diagnosis in a memory clinic cohortJordi Sarto, Diana Esteller-Gauxax, Núria Guillén, et al.
Journal of Neurology|December 16, 2025
Plasma p-Tau217 and GFAP predict widespread cognitive decline in Alzheimer's diseaseNúria Guillén, Diana Esteller, Jordi Sarto, et al.
Neurology|July 1, 2026
Neuropsychological Profile and Cognitive Trajectories of Patients With Biomarker Evidence of Alzheimer Disease or Dementia With Lewy bodiesAdrià Tort-Merino, Diana Esteller-Gauxax, Agnès Pérez-Millan, et al.
Annals of Clinical and Translational Neurology|April 13, 2026
Predictive Ability of Plasma p-tau217 for β-Amyloid Status: A Prospective Multicenter StudyMiquel Massons, Nuria Guillen, Jordi Sarto, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersMiquel Massons, Jordi Sarto, Núria Guillén, et al.
Pageof 1